TickerFactsScreenerDevelopers

Contineum Therapeutics, Inc. (CTNM) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: $19.35M2024: -$32.84M2025: -$55.31M-$55.31M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$55.31M-68.4%
2024-$32.84M-269.8%
2023$19.35M—